Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus | 3 | 2024 | 531 | 1.360 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 89 | 0.820 |
Why?
|
| Prediabetic State | 1 | 2024 | 68 | 0.810 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 107 | 0.790 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2020 | 744 | 0.610 |
Why?
|
| Community Networks | 3 | 2009 | 106 | 0.560 |
Why?
|
| Quality Assurance, Health Care | 2 | 2008 | 55 | 0.530 |
Why?
|
| Medicaid | 4 | 2025 | 138 | 0.490 |
Why?
|
| Propensity Score | 2 | 2024 | 58 | 0.440 |
Why?
|
| Health Promotion | 2 | 2010 | 691 | 0.400 |
Why?
|
| Adult | 17 | 2025 | 13437 | 0.370 |
Why?
|
| Program Evaluation | 3 | 2012 | 357 | 0.340 |
Why?
|
| Health Education | 3 | 2014 | 358 | 0.340 |
Why?
|
| Program Development | 2 | 2009 | 237 | 0.340 |
Why?
|
| Remote Consultation | 1 | 2010 | 8 | 0.320 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 64 | 0.310 |
Why?
|
| Aged | 9 | 2024 | 7958 | 0.310 |
Why?
|
| Disease Management | 1 | 2010 | 68 | 0.310 |
Why?
|
| Middle Aged | 11 | 2025 | 11790 | 0.300 |
Why?
|
| Female | 20 | 2025 | 23980 | 0.290 |
Why?
|
| Humans | 25 | 2025 | 42113 | 0.280 |
Why?
|
| Point-of-Care Systems | 1 | 2008 | 35 | 0.270 |
Why?
|
| Male | 16 | 2025 | 22745 | 0.260 |
Why?
|
| United States | 6 | 2025 | 5068 | 0.230 |
Why?
|
| Physicians | 2 | 2008 | 180 | 0.230 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 680 | 0.230 |
Why?
|
| Prenatal Care | 1 | 2006 | 82 | 0.230 |
Why?
|
| Primary Health Care | 4 | 2005 | 362 | 0.230 |
Why?
|
| Blood Glucose | 2 | 2016 | 386 | 0.230 |
Why?
|
| HIV Infections | 4 | 2025 | 2535 | 0.230 |
Why?
|
| Community Health Centers | 2 | 2020 | 56 | 0.220 |
Why?
|
| Analgesia, Epidural | 1 | 2004 | 6 | 0.220 |
Why?
|
| Prevalence | 3 | 2024 | 1593 | 0.220 |
Why?
|
| Analgesia, Obstetrical | 1 | 2004 | 4 | 0.220 |
Why?
|
| Risk Factors | 7 | 2025 | 3933 | 0.220 |
Why?
|
| Mississippi | 1 | 2024 | 129 | 0.210 |
Why?
|
| Cohort Studies | 3 | 2024 | 1728 | 0.210 |
Why?
|
| Cause of Death | 1 | 2024 | 183 | 0.210 |
Why?
|
| Public Opinion | 1 | 2003 | 20 | 0.200 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 263 | 0.200 |
Why?
|
| Cognition Disorders | 1 | 2005 | 243 | 0.200 |
Why?
|
| Faculty, Medical | 1 | 2003 | 74 | 0.190 |
Why?
|
| Complementary Therapies | 1 | 2003 | 51 | 0.190 |
Why?
|
| Vitamin D | 1 | 2024 | 196 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 570 | 0.190 |
Why?
|
| Incidence | 1 | 2024 | 1052 | 0.180 |
Why?
|
| Heart Failure | 1 | 2005 | 298 | 0.170 |
Why?
|
| Attitude of Health Personnel | 1 | 2003 | 222 | 0.170 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 3073 | 0.170 |
Why?
|
| Mass Screening | 3 | 2016 | 531 | 0.170 |
Why?
|
| Young Adult | 4 | 2025 | 4928 | 0.150 |
Why?
|
| Georgia | 6 | 2017 | 189 | 0.150 |
Why?
|
| Community-Institutional Relations | 2 | 2012 | 208 | 0.140 |
Why?
|
| Self Care | 1 | 2020 | 173 | 0.140 |
Why?
|
| Medication Adherence | 1 | 2020 | 177 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 181 | 0.140 |
Why?
|
| Soft Tissue Infections | 1 | 2017 | 6 | 0.130 |
Why?
|
| Logistic Models | 4 | 2016 | 1001 | 0.130 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2017 | 10 | 0.130 |
Why?
|
| Carrier State | 1 | 2017 | 33 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 62 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2010 | 584 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2016 | 844 | 0.110 |
Why?
|
| Adolescent | 6 | 2016 | 5949 | 0.110 |
Why?
|
| Inservice Training | 1 | 2014 | 33 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 415 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 959 | 0.100 |
Why?
|
| Community Health Services | 2 | 2012 | 207 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 2790 | 0.090 |
Why?
|
| Preventive Health Services | 1 | 2012 | 65 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2012 | 137 | 0.090 |
Why?
|
| Health Behavior | 4 | 2012 | 568 | 0.090 |
Why?
|
| Capacity Building | 1 | 2012 | 99 | 0.090 |
Why?
|
| Unsafe Sex | 1 | 2012 | 162 | 0.080 |
Why?
|
| Telephone | 1 | 2010 | 35 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2012 | 225 | 0.080 |
Why?
|
| Age Distribution | 3 | 2005 | 249 | 0.080 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 33 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2010 | 162 | 0.080 |
Why?
|
| Health Planning Technical Assistance | 1 | 2009 | 5 | 0.080 |
Why?
|
| Training Support | 1 | 2009 | 8 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 85 | 0.070 |
Why?
|
| Financial Support | 1 | 2008 | 7 | 0.070 |
Why?
|
| Community-Based Participatory Research | 1 | 2012 | 336 | 0.070 |
Why?
|
| Drug Industry | 1 | 2008 | 18 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2008 | 63 | 0.070 |
Why?
|
| Goals | 1 | 2008 | 33 | 0.070 |
Why?
|
| Schools, Medical | 2 | 2012 | 208 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 637 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2005 | 224 | 0.070 |
Why?
|
| Urban Population | 1 | 2010 | 364 | 0.070 |
Why?
|
| Health Literacy | 1 | 2010 | 120 | 0.070 |
Why?
|
| Nurses | 1 | 2008 | 55 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 574 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2008 | 427 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2010 | 1570 | 0.060 |
Why?
|
| Comorbidity | 2 | 2005 | 723 | 0.060 |
Why?
|
| Registries | 2 | 2005 | 430 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2005 | 51 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 195 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 97 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2008 | 733 | 0.060 |
Why?
|
| Poverty | 2 | 2010 | 395 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 146 | 0.050 |
Why?
|
| Labor, Obstetric | 1 | 2004 | 16 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1221 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2004 | 47 | 0.050 |
Why?
|
| Education, Medical | 1 | 2005 | 117 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2006 | 335 | 0.050 |
Why?
|
| Carcinoma | 1 | 2004 | 106 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2004 | 84 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 250 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 704 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2009 | 702 | 0.050 |
Why?
|
| Prognosis | 1 | 2005 | 847 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 309 | 0.050 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2003 | 172 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2466 | 0.040 |
Why?
|
| Pregnancy | 1 | 2004 | 1733 | 0.040 |
Why?
|
| Hypertension | 1 | 2005 | 817 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 95 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 157 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 232 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 91 | 0.030 |
Why?
|
| Problem Solving | 1 | 2014 | 38 | 0.030 |
Why?
|
| Indians, North American | 1 | 2016 | 179 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 960 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1265 | 0.030 |
Why?
|
| Leadership | 1 | 2014 | 84 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1142 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2014 | 110 | 0.020 |
Why?
|
| Peer Group | 1 | 2014 | 173 | 0.020 |
Why?
|
| Internet | 1 | 2014 | 234 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2017 | 1515 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2012 | 35 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 1679 | 0.020 |
Why?
|
| Health Services Research | 1 | 2012 | 161 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2005 | 1582 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2012 | 523 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 210 | 0.020 |
Why?
|
| Child | 1 | 2017 | 3381 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 233 | 0.020 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2005 | 108 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 59 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 64 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 82 | 0.010 |
Why?
|
| Indiana | 1 | 2003 | 16 | 0.010 |
Why?
|
| New Jersey | 1 | 2003 | 15 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2004 | 116 | 0.010 |
Why?
|
| Washington | 1 | 2003 | 36 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 158 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 224 | 0.010 |
Why?
|
| Marital Status | 1 | 2003 | 46 | 0.010 |
Why?
|
| Insurance Claim Review | 1 | 2003 | 35 | 0.010 |
Why?
|
| Syphilis | 1 | 2003 | 24 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 362 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 366 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 285 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 211 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 335 | 0.010 |
Why?
|
| Age Factors | 1 | 2003 | 1135 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 663 | 0.010 |
Why?
|